Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tremfya (guselkumab)
Biotech
J&J's CMO William Hait slated to depart this fall
Johnson & Johnson EVP, Chief External Innovation and Medical Officer William Hait, M.D., Ph.D., will be hanging up his hat this September.
Gabrielle Masson
Jun 11, 2024 10:41am
Innovent looks to Chinese regulators after ph. 3 psoriasis win
May 28, 2024 7:55am
Innovent’s rival to AbbVie, J&J psoriasis drugs clears phase 2
Aug 10, 2022 6:50am
